Corrigendum: Estrogens modulate somatostatin receptors expression and synergize with the somatostatin analog pasireotide in prostate cells

Corrigendum: Estrogens modulate somatostatin receptors expression and synergize with the somatostatin analog pasireotide in prostate cells

Saved in:

Bibliographic Details
Main Authors:	Valentina Rossi, Erika Di Zazzo, Giovanni Galasso, Caterina De Rosa, Ciro Abbondanza, Antonio A. Sinisi, Lucia Altucci, Antimo Migliaccio, Gabriella Castoria
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Pharmacology
Subjects:	prostate cancer estrogens somatostatin analogs somatostatin receptors apoptosis EMT
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1515349/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Structural insights into the binding modes of lanreotide and pasireotide with somatostatin receptor 1
by: Zicheng Zeng, et al.
Published: (2025-05-01)

The Role of Somatostatin in the Gastrointestinal Tract
by: Konstantinos Papantoniou, et al.
Published: (2025-05-01)

Long-Term Results of Cabergoline Add-on Long-Acting Somatostatin Analogue Therapy in Acromegaly Patients
by: Mehmet Muhittin Yalçın, et al.
Published: (2024-10-01)

SOMATOSTATIN RECEPTORS AS POTENTIALTHERAPEUTIC TARGETS IN THE TREATMENT OF ADVANCED ADRENOCORTICAL CANCER. A CASE REPORT
by: A. A. Kolomeytseva, et al.
Published: (2018-05-01)

“Cold” Somatostatin Analogs in Neuroendocrine Neoplasms: Decoding Mechanisms, Overcoming Resistance, and Shaping the Future of Therapy
by: Sara Massironi, et al.
Published: (2025-02-01)

Molecular identification of somatostatin family in tilapia and the effect of food intake on pss2 and sstr3a
by: Ran Cai, et al.
Published: (2025-04-01)

Does treatment with somatostatin analogs differ in the uptake of normal target organs and malignant lesions on 68Ga-DOTATATE PET/CT imaging?
by: Çağlagül Erol, et al.
Published: (2022-08-01)

Comparative analysis of adverse event profiles of lanreotide and octreotide in somatostatin-responsive endocrine and neoplastic diseases
by: Le Wang, et al.
Published: (2025-05-01)

Insulinoma with suspected mutant somatostatin receptor expression according to histological examination
by: Shunichiro Onish, et al.
Published: (2024-11-01)

Primary pancreatic lymphoma camouflaged under the umbrella of spectrum of neuroendocrine tumors in somatostatin receptor imaging
by: Nikita Sampathirao, et al.
Published: (2020-07-01)

Efficacy and predictors of response to somatostatin analogues in patients with ectopic ACTH syndrome
by: Olga O. Golounina, et al.
Published: (2024-12-01)

Insight into the Potential of Somatostatin Vaccination with Goats as a Model: From a Perspective of the Gastrointestinal Microbiota
by: Xiaoli Zhang, et al.
Published: (2025-03-01)

Somatostatin Receptor Imaging in the Diagnosis and Management of Parathyroid Neuroendocrine Neoplasia
by: Uliana Tsoy, et al.
Published: (2024-12-01)

Somatostatin receptor expression in multiple hemangiomas
by: Benjin Liu, et al.
Published: (2025-07-01)

Everolimus-induced somatostatin receptor overexpression in a rectal neuroendocrine tumor patient may promote somatostatin receptor-guided radionuclide therapy (peptide receptor radiotherapy) as an additional treatment option
by: Magdalena Mileva, et al.
Published: (2021-07-01)

Somatostatin receptor molecular imaging in a misdiagnosed gastrinoma case
by: Cati Stolniceanu, et al.
Published: (2020-10-01)

The Investigation of Somatostatin Receptors as a Potential Target in Breast Phyllodes Tumours
by: Hande Süer Mickler, et al.
Published: (2024-12-01)

Somatostatin does not attenuate intestinal injury in dextran sodium sulphate-induced subacute colitis
by: J. D. van Bergeijk, et al.
Published: (1998-01-01)

Protective Effects of Pasireotide in LPS-Induced Acute Lung Injury
by: Saikat Fakir, et al.
Published: (2025-06-01)

“Rosary Sign” at Somatostatin Receptor PET in a Case of Recurrent Meningioma
by: Cesare Michele Iacovitti, et al.
Published: (2024-11-01)

Effect of Bacillus cereus PAS38 and mannosan preparation on immunoreactive cells of somatostatin and 5-HT in small intestine of rabbit
by: PAN Kang-cheng, et al.
Published: (2009-09-01)

Pyridyl-Ala in the third position of radiolabeled somatostatin antagonists: the effect of regioisomeric substitution
by: Rosalba Mansi, et al.
Published: (2025-07-01)

Crosstalk of TGF-β and somatostatin signaling in adenocarcinoma and neuroendocrine tumors of the pancreas: a brief review
by: Hendrik Ungefroren, et al.
Published: (2025-03-01)

Alterations in hippocampal somatostatin interneurons, GABAergic metabolism, and ASL perfusion in an aged male mouse model of POCD aggravated by sleep fragmentation
by: Yun Li, et al.
Published: (2024-12-01)

Bidirectional modulation of somatostatin-expressing interneurons in the basolateral amygdala reduces neuropathic pain perception in mice
by: Aditya Apte, et al.
Published: (2025-08-01)

Somatostatin-expressing interneurons of prefrontal cortex modulate social deficits in the Magel2 mouse model of autism
by: Xiaona Wang, et al.
Published: (2025-03-01)

Somatostatin Mitigates Gastric Mucosal Damage Induced by LPS in a Male Wistar Rat Model of Sepsis
by: Sergio D. Paredes, et al.
Published: (2025-03-01)

Somatostatin-containing protein-based drug in the treatment of infertility: efficacy evaluation using a leuprorelin-induced spermatogenesis impairment model in male rats
by: A. A. Matichin, et al.
Published: (2025-07-01)

Safety, dosimetry, and efficacy of an optimized long-acting somatostatin analog for peptide receptor radionuclide therapy in metastatic neuroendocrine tumors: From preclinical testing to first-in-human study
by: Wei Guo, et al.
Published: (2025-02-01)

A Systematic Review and Meta-Analysis on the Role of Somatostatin Therapy in Non-Variceal Gastrointestinal Bleeding
by: Magnus Chun, et al.
Published: (2025-06-01)

Evaluating the diagnostic accuracy of 99mTc-labeled somatostatin receptor imaging for suspected pheochromocytomas and paragangliomas
by: Bo Li, et al.
Published: (2025-07-01)

Real-Life Data on the Safety of Pasireotide in Acromegaly: Insights from EudraVigilance
by: Ioana Rada Popa Ilie, et al.
Published: (2024-12-01)

Somatostatin interneuron fate-mapping and structure in a Pten knockout model of epilepsy
by: Austin W. Drake, et al.
Published: (2024-10-01)

THERAPY WITH SOMATOSTATIN ANALOGUES IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
by: K. Y. Kanukoev, et al.
Published: (2015-04-01)

Congenital Chylothorax in a Late Preterm Infant and Successful Treatment With Octreotide
by: Ning-Hui Foo, et al.
Published: (2011-10-01)

Unmasking insulinoma following commencement of somatostatin analogues in malignant neuroendocrine tumours
by: Isuru Gamage, et al.
Published: (2025-07-01)

Age-dependent patterns of somatostatinergic neurons in sympathetic paravertebral ganglia
by: A. I. Emanuilov, et al.
Published: (2023-10-01)

Effects of Cholinergic and Opioid Antagonists on In Vitro Release of Met-Enkephalin, Somatostatin and Insulin-like Growth Factor-1 by and PENK Expression in Crop, Proventriculus and Duodenum of Newly Hatched Chickens
by: Colin G. Scanes, et al.
Published: (2025-06-01)

Effects of lanreotide autogel immediately after a single injection for thyrotropin-producing pituitary tumor
by: Mayuko Sumitomo, et al.
Published: (2025-06-01)

Real-World Study of Lanreotide Autogel in Routine Practice in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Hong Kong and Taiwan
by: Jen-Shi Chen, et al.
Published: (2024-08-01)